TRICARE covers certain GLP-1 medications for qualifying beneficiaries
GLP-1 medications are typically prescribed for individuals who have a body mass index (BMI) of 30 or higher, or for those with a BMI of 27 or higher who also have at least one weight-related health condition, such as type 2 diabetes or high blood pressure
Your body needs approximately 4 weeks at each dose level to adapt
Unlike conventional weight-loss medications, retatrutide works on three metabolic hormone receptors simultaneously, offering a more comprehensive approach to obesity, metabolic disease, and fat redistribution concerns that are increasingly prevalent in urban Indian populations
Interestingly, a new version of GLP-1s known as tirzepatide (Mounjaro) may be more effective than semaglutide
Registered dietitians emphasized the importance of using visual tools, such as the MyPlate and Healthy Eating Plate models, to improve patient comprehension of portion sizes and nutrient intake